Search for a command to run...
Global Longlife Hospital and Research Ltd. is currently underperforming against its peers in terms of growth, profitability, and valuation metrics. However, due to its low debt levels, it could be considered a deep value pick for investors looking for potential upside as the company stabilizes. Peers like Max Healthcare and Apollo Hospitals are strong performers due to robust growth and profitability metrics, making them leaders in the sector.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Global Longlife Hospital and Research Ltd. | ₹26.40 | ₹27.72Cr | 139.98 | - | - |
MAXHEALTH | ₹1,179.65 | ₹1,14,679.30Cr | 163.58 | 16.26% | 0.14 |
APOLLOHOSP | ₹7,676.95 | ₹1,10,383.03Cr | 85.15 | 21.19% | 0.67 |
FORTIS | ₹924.85 | ₹69,822.29Cr | 1094.63 | 12.01% | 0.11 |
MEDANTA | ₹1,395.25 | ₹37,474.60Cr | 81.26 | 20.50% | 0.10 |
NH | ₹1,784.05 | ₹36,459.02Cr | 84.56 | 21.62% | 0.61 |
ASTERDM | ₹605.10 | ₹30,225.53Cr | 5.05 | 11.46% | 0.19 |